Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
about
Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5AeIF5A isoforms and cancer: two brothers for two functions?Trespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culpritsThe unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.Characterization of a eukaryotic translation initiation factor 5A homolog from Tamarix androssowii involved in plant abiotic stress tolerance.Cancer gene discovery in hepatocellular carcinomaInhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancerCisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancerProduction of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1.Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development.Loss of elongation factor P disrupts bacterial outer membrane integrityElongation factor P mediates a novel post-transcriptional regulatory pathway critical for bacterial virulenceThe translation factor eIF5A and human cancer.Translational control in cancer etiology.Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cellsRoles of eukaryotic initiation factor 5A2 in human cancer.A new non-radioactive deoxyhypusine synthase assay adaptable to high throughput screening.Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.The spermidine analogue GC7 (N1-guanyl-1,7-diamineoheptane) induces autophagy through a mechanism not involving the hypusination of eIF5A.Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells.Selenium mediated arsenic toxicity modifies cytotoxicity, reactive oxygen species and phosphorylated proteins.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.Eukaryotic translation initiation factors and cancer.The effect of miR-7 on behavior and global protein expression in glioma cell lines.Protein-protein-interaction network organization of the hypusine modification system.Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2.The Role of Acetylation in the Subcellular Localization of an Oncogenic Isoform of Translation Factor eIF5AMicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2
P2860
Q24292717-060B2CF8-E2B3-4E87-8317-8E5A81DB31B0Q26830163-C934E8D0-5B31-4918-A3B9-4EC4DA7F1FD7Q26997307-61F6B34B-2708-4583-ACD6-51AE67E3E6FAQ30435990-E1275BBA-4214-471D-9A83-3EDC1ED38900Q31077285-A523C6DB-97E2-4419-8BDB-C512AF1B0687Q34002120-1F13A828-DE78-4838-9EFD-D34F114B365AQ34019744-D8A6E23D-B12A-437D-9B53-40BDB13FAFFEQ34137202-A5B504AE-A8AF-4886-A540-ACDBFEE2A698Q34345765-72D1B33A-FDDA-4A63-A205-22DA0A257FD2Q34515582-5AB93A67-D51E-4F25-A9C9-26778EDACA7CQ34518559-9CF08C29-999F-4F4C-8772-70BF97345745Q34571712-6003EF62-F776-4CC8-975F-EBCAC843C2D1Q34641660-272E3FFB-959E-4AAD-BD71-0DD29E18C28FQ34965348-3AB5323A-3C53-4651-98EB-1E66970A6533Q35563868-6236FBE3-0AF7-457C-8DF7-2D14A2B0C524Q35668094-C426A3C5-0D8C-47C8-84DE-13FFC896AEB0Q35693689-38B809EB-6900-4B61-AF47-AB09A33C23D4Q36519353-22727DCA-ACC4-4E36-8D53-AAD25BC5A220Q36555212-D9727043-5A3E-4EAF-94E1-8D3557E81C1CQ36557053-53111666-8331-4B85-A7F5-5E599E3E4F00Q36863596-B1A3E61B-BC43-4B8A-AA72-0349F9ECEF80Q38163977-17E11ED5-D407-4A72-A4D5-30648C26D5D9Q38618845-3D60E2A2-6243-4966-93D7-895780CF90A6Q38843125-8F7A1F5B-6E59-4506-AC54-BB7FFC074573Q38956908-CB78112A-6AB6-441D-AD6E-C61BF0AB5C87Q39144255-E2B09C15-E06F-42E5-9F3B-CFB342F709D5Q39179665-B1F4EF95-7206-4BEB-8421-262CDF92BE4BQ39186868-A650A89C-D136-4BF1-8721-7EB6BB91850DQ39380134-10BF1317-D400-4DB5-9549-DC776A6D21B4Q39400409-5D7BE83E-B0AC-4DB1-A40E-CCE6FD907E8DQ39436568-BF6A1743-158A-4C86-A825-B0D2AD4FF960Q41295369-E8516E77-F5AC-4444-9539-A35D05A821FAQ41789947-F4AA1567-311C-4F8E-B773-9BFCF181F8E3Q42639936-3EAD441C-2C28-472B-AFF7-47F508C8FA4DQ48879179-2C6F9351-9AD9-4980-BF29-3A449ED0BA91Q49335206-1B2A604C-3DE7-4604-8602-9A588B4A1E1CQ57228540-AE48BF89-699B-46D7-8F2B-3900B7262551Q58800121-56A6F402-1FA8-44F0-8E2B-4444192D1613
P2860
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@ast
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@en
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@nl
type
label
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@ast
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@en
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@nl
prefLabel
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@ast
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@en
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
@nl
P2093
P2860
P1433
P1476
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells
@en
P2093
Edith C Wolff
Myung H Park
Paul M J Clement
P2860
P304
P356
10.1111/J.1742-4658.2006.05135.X
P407
P577
2006-03-01T00:00:00Z